Cargando…

Commentary: Characteristics and Long-Term Ablation Outcomes of Supraventricular Arrhythmias in Hypertrophic Cardiomyopathy: A 10-Year, Single-Center Experience

Detalles Bibliográficos
Autores principales:	Shen, Rui-Huan, Zou, Tong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964932/ https://www.ncbi.nlm.nih.gov/pubmed/35369307 http://dx.doi.org/10.3389/fcvm.2022.831343

Ejemplares similares

Characteristics and Long-Term Ablation Outcomes of Supraventricular Arrhythmias in Hypertrophic Cardiomyopathy: A 10-Year, Single-Center Experience
por: Zhang, Hong-Da, et al.
Publicado: (2021)

Ventricular Arrhythmia in Septal and Apical Hypertrophic Cardiomyopathy: The French-Canadian Experience
por: Steinberg, Christian, et al.
Publicado: (2020)

Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
por: Shen, Hua, et al.
Publicado: (2022)

Catheter ablation in Asian patients with atrial fibrillation and hypertrophic cardiomyopathy: electrophysiological characteristics of recurrence and long-term clinical outcomes
por: Lin, Chih-Hsien, et al.
Publicado: (2023)

Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation
por: Meng, Xiangbin, et al.
Publicado: (2022)

Global Circumferential Strain by Cardiac Magnetic Resonance Tissue Tracking Associated With Ventricular Arrhythmias in Hypertrophic Cardiomyopathy Patients
por: Pu, Cailing, et al.
Publicado: (2021)

First-in-man application of Liwen RF™ ablation system in the treatment of drug-resistant hypertrophic obstructive cardiomyopathy
por: Wang, Zihao, et al.
Publicado: (2022)

Mean Scar Entropy by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Associated With Ventricular Arrhythmias Events in Hypertrophic Cardiomyopathy
por: Ye, Yang, et al.
Publicado: (2021)

Selective Interventricular Septal Radiofrequency Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?
por: Liu, Qiang, et al.
Publicado: (2021)

Safety and efficacy of zero-fluoroscopy catheter ablation for paroxysmal supraventricular tachycardia in Chinese children
por: Cui, Xiaoran, et al.
Publicado: (2022)

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021)

Zero and Minimal Fluoroscopic Approaches During Ablation of Supraventricular Tachycardias: A Systematic Review and Meta-Analysis
por: Debreceni, Dorottya, et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment
por: Cheng, Zeyi, et al.
Publicado: (2021)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Routine use of a 3D mapping system in the ablation of supraventricular arrhythmias with as low as reasonably achievable X-ray exposure (AALARA): protocol for a prospective, observational, multicentre, multinational, open-label registry study
por: Szegedi, Nandor, et al.
Publicado: (2023)

Thoracoscopic Trans-mitral Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy in the Elderly
por: Wei, Peijian, et al.
Publicado: (2022)

Alcohol Septal Ablation or Septal Myectomy? An Updated Systematic Review and Meta-Analysis of Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
por: Zheng, Xifeng, et al.
Publicado: (2022)

Anxiety Predicts Poor Prognosis in Patients With Hypertrophic Cardiomyopathy
por: He, Chao-Jie, et al.
Publicado: (2022)

Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
por: Burkart, Valentin, et al.
Publicado: (2022)

Cardiovascular Imaging in Pregnancy: Valvulopathy, Hypertrophic Cardiomyopathy, and Aortopathy
por: Ismail, Haneen, et al.
Publicado: (2022)

A Systemic Mapping Approach for Right and Left Parahisian Ventricular Arrhythmias Ablation
por: Kong, Ling-cong, et al.
Publicado: (2022)

EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM)—rationale and design: a prospective observational study on incidence of arrhythmias in Sweden
por: Magnusson, Peter, et al.
Publicado: (2017)

Hemodynamic response to supraventricular tachycardia in a patient with hypertrophic cardiomyopathy
por: Ebrille, Elisa, et al.
Publicado: (2018)

Non-pharmaceutical Interventions for Hypertrophic Cardiomyopathy: A Mini Review
por: He, Miaomiao, et al.
Publicado: (2021)

Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era
por: Butzner, Michael, et al.
Publicado: (2022)

Further Considerations in Childhood-Onset Hypertrophic Cardiomyopathy Genetic Testing
por: Monasky, Michelle M., et al.
Publicado: (2021)

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2022)

Significance and Determinants of Plasma Apelin in Patients With Obstructive Hypertrophic Cardiomyopathy
por: Yang, Chengzhi, et al.
Publicado: (2022)

Case report: Metastatic melanoma masquerading as apical hypertrophic cardiomyopathy
por: Ashraf, Muddasir, et al.
Publicado: (2022)

Advanced searching for hypertrophic cardiomyopathy heritability in real practice tomorrow
por: Chumakova, Olga S., et al.
Publicado: (2023)

Ventricular arrhythmias originating from the basal septum of the ventricle: Clinical and electrophysiological characteristics and a systematic ablation approach
por: Shi, Linsheng, et al.
Publicado: (2022)

Understanding the scope of intracardiac echocardiography in catheter ablation of ventricular arrhythmia
por: Ma, Chuanzhen, et al.
Publicado: (2022)

Supraventricular arrhythmia in pregnancy
por: Ramlakhan, Karishma P, et al.
Publicado: (2022)

Zero Fluoroscopy Arrhythmias Catheter Ablation: A Trend Toward More Frequent Practice in a High-Volume Center
por: Troisi, Federica, et al.
Publicado: (2022)

The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy
por: Aguiar Rosa, Sílvia, et al.
Publicado: (2021)

Basic science methods for the characterization of variants of uncertain significance in hypertrophic cardiomyopathy
por: Doh, Chang Yoon, et al.
Publicado: (2023)

Risk factors, clinical features, and outcomes of patients with hypertrophic cardiomyopathy complicated by ischemic stroke: A single-center retrospective study
por: Lu, Jian-Feng, et al.
Publicado: (2022)

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance
por: Izquierdo, Cristian, et al.
Publicado: (2021)

A novel compound heterozygous variant in ALPK3 induced hypertrophic cardiomyopathy: a case report
por: Li, Tiange, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oeflu9uca3bkc0iam3tnt1n1je